Alprazolam (Page 7 of 7)
When rats were treated with alprazolam at 3, 10, and 30 mg/kg/day (15 to 150 times the maximum recommended human dose) orally for 2 years, a tendency for a dose related increase in the number of cataracts was observed in females and a tendency for a dose related increase in corneal vascularization was observed in males. These lesions did not appear until after 11 months of treatment.
DAVA Pharmaceuticals, Inc.
Fort Lee, NJ 07024, USA
ULTRAtab Laboratories, Inc.
Highland, NY 12528, USA
Alprazolam Tablets contain alprazolam which is a triazolo analog of the 1,4 benzodiazepine class of central nervous system-active compounds.
The chemical name of alprazolam is 8-Chloro-1-methyl-6-phenyl-4H-s-triazolo [4,3-1] [1,4] benzodiazepine.
The structural formula is represented to the right:
Alprazolam is a white to off-white crystalline powder, which is soluble in methanol or ethanol but which has no appreciable solubility in water at physiological pH.
Each ALPRAZOLAM Tablet, for oral administration, contains 0.25, 0.5, 1 or 2 mg of alprazolam.
Inactive ingredients: crospovidone, docusate sodium, lactose, magnesium stearate, microcrystalline cellulose, silicon dioxide, sodium benzoate and starch 1500. In addition, the 0.5 mg tablet contains D&C Yellow No. 10 and the 1 mg and 2 mg tablet contains Green Lake Blend.
Principal Display Panel
Alprazolam Tablets, USP 0.25mg CIV
|ALPRAZOLAM alprazolam tablet|
|Labeler — Blenheim Pharmacal, Inc. (171434587)|
|Registrant — Blenheim Pharmacal, Inc. (171434587)|
|Blenheim Pharmacal, Inc.||171434587||repack (10544-118)|
Revised: 10/2015 Blenheim Pharmacal, Inc.
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.